ANGELA ADAMS: Open Payments
NPI 1881099471 · DE SOTO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 56 payments from 18 companies in 2025. Trend: 2023 $1,022 · 2024 $595 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $204 |
| AstraZeneca Pharmaceuticals LP | 10 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $146 |
| Lilly USA, LLC | 4 | $76 |
| Aimmune Therapeutics, Inc. | 3 | $68 |
| Lundbeck LLC | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Agios Pharmaceuticals, Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: CAPLYTA, AIRSUPRA, VRAYLAR, QULIPTA, REXULTI, MOUNJARO, BREZTRI, VOWST.
Industry payments across MO — which companies pay providers there.
